A randomized phase III trial of the Southern Italy Oncology Group (G.O.I.M.). of mitomycin C plus vindesine and cisplatin (MVP regimen) versus vinorelbine plus cisplatin (PV regimen) in stage III–IV non small cell lung cancerDomenico Galetta, Giuseppe Colucci, Ferdinando Riccardi et al.|Lung Cancer|2000Cited by 3